<PAGE>
-----------------------------
| OMB APPROVAL |
|----------------------------
|OMB Number: 3235-0145 |
|Expires: December 31, 1997 |
|Estimated average burden |
|hours per response....14.90|
-----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 6 )*
----------
ROBERTS PHARMACEUTICAL CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class Securities)
770491-10-8
--------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this coverage page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 pages
<PAGE>
CUSIP NO. 770491-10-8 13G Page 2 of 5 Pages
1. NAME OF REPORTING PERSON
S.S or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert A. Vukovich
Social Security No. ###-##-####
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- -------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
5. SOLE VOTING POWER
1,887,571
--------------------------------------------------------
6. SHARED VOTING POWER
0
--------------------------------------------------------
7. SOLE DISPOSITIVE POWER
1,887,571
--------------------------------------------------------
8. SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,887,571
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
N/A
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
1,887,571
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
Page 2 of 5 pages
<PAGE>
SCHEDULE 13G (continued)
Item 1.
(a) Name of Issuer:
Roberts Pharmaceutical Corporation
(b) Address of Issuer's Principal Executive Offices:
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
Item 2.
(a) Name of Person Filing:
Robert A. Vukovich
(b) Address of Principal Office or, if none, Residence:
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
(c) Citizenship:
U.S.A.
(d) Title of Class of Securities
Common Stock, $.01 par value
(e) CUSIP Number:
770491-10-8
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or
13d-2(b), check whether the person filing is a:
Not Applicable.
Item 4. Ownership (as of December 31, 1995)
(a) Amount Beneficially Owned: 1,887,571
(b) Percent of Class: 8.7%
Page 3 of 5
<PAGE>
(c) Number of Shares as to which such person has:
(i) sole power to vote or to direct the vote of 1,887,571
---------
shares including 250,000 shares subject to a currently
-------
exercisable option.
(ii) shared power to vote or to direct the vote of 0
---
shares.
(iii) sole power to dispose or to direct the disposition of
1,887,571 shares including 250,000 shares subject to a
--------- -------
currently exercisable option.
(iv) shared power to dispose of or to direct the disposition
of 0 shares.
---
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not Applicable
ITEM 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT
HOLDING COMPANY
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
Page 4 of 5
<PAGE>
ITEM 10. CERTIFICATION
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: January 29, 1996
/s/ Robert A. Vukovich
- -----------------------
Signature
Robert A. Vukovich
Chairman of the Board and
President
- -------------------------
Name/Title
Page 5 of 5
